These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 24173182)

  • 1. Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment.
    Silva MF; Fortes MR; Miot LD; Marques SA
    An Bras Dermatol; 2013; 88(5):760-3. PubMed ID: 24173182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
    Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
    J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
    Mattei PL; Corey KC; Kimball AB
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain.
    Daudén E; Vidal D; Romero A; Bordel MT; Rivera R; Márquez J; Zamora E; Martinez L; Ocaña MJ; Vila C; Iribarren P; Corona N; Zulaica A
    Actas Dermosifiliogr; 2024 Jan; 115(1):T1-T9. PubMed ID: 37923068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain.
    Daudén E; Vidal D; Romero A; Bordel MT; Rivera R; Márquez J; Zamora E; Martinez L; Ocaña MJ; Vila C; Iribarren P; Corona N; Zulaica A
    Actas Dermosifiliogr; 2024 Jan; 115(1):1-9. PubMed ID: 37429433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study.
    Chen Y; Wei L; Song Y; Zhang R; Kuai L; Li B; Wang R
    Ann Med; 2023 Dec; 55(1):2231847. PubMed ID: 37417705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CoQ10 Administration to Psoriatic Iraqi Patients on Biological Therapy Upon Severity Index (PASI) and Quality of Life Index (DLQI) Before and After Therapy.
    Al-Oudah GA; Sahib AS; Al-Hattab MK; Al-Ameedee AA
    J Popul Ther Clin Pharmacol; 2022; 29(2):e52-e60. PubMed ID: 35848197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observational study in Central and Eastern European countries.
    Raam L; Hartmane I; Valiukevičienė S; Karamova AE; Telegdy E; Botev I; Marina D; Rubant S; Albuquerque T; Constantin MM
    Front Immunol; 2024; 15():1410540. PubMed ID: 38846952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between quality of life and the severity of psoriasis in Turkey.
    Çakmur H; Derviş E
    Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study.
    Loft ND; Egeberg A; Rasmussen MK; Bryld LE; Gniadecki R; Dam TN; Iversen L; Skov L
    Acta Derm Venereol; 2019 Dec; 99(13):1224-1230. PubMed ID: 31580465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
    Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
    Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-Term Correlation of the Psoriasis Area Severity Index, the Nail Psoriasis Area Severity Index, and the Dermatology Life Quality Index, before and after Treatment, in Patients with Skin and Nail Psoriasis.
    Prevezas C; Katoulis AC; Papadavid E; Panagakis P; Rigopoulos D
    Skin Appendage Disord; 2019 Nov; 5(6):344-349. PubMed ID: 31799260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
    Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
    Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
    Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study.
    Cozzani E; Linder D; Burlando M; Gallo F; Sampogna F; Bruzzone M; Tacchino C; Drago F; Parodi A
    Eur J Dermatol; 2018 Jun; 28(3):332-337. PubMed ID: 29789272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Disease Activity and Quality of Life of Patients with Psoriasis after Narrow-band Ultraviolet B Therapy.
    Dourmishev LA; Lyubomirova K
    Folia Med (Plovdiv); 2020 Mar; 62(1):89-93. PubMed ID: 32337912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
    Abrouk M; Nakamura M; Zhu TH; Farahnik B; Koo J; Bhutani T
    J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients.
    Zou Q; Luo Y; Hao D; Li M; Jihui C
    J Health Popul Nutr; 2024 Jun; 43(1):92. PubMed ID: 38909238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.